Stevanato Group
- Market cap
- 5.31B
- P/E (TTM)i
- 35.41
- P/Bi
- 3.06
- EPSi
- 0.57
- Div yieldi
- 0.32%
- 52W posi
- 44%
Anonymous reader poll. Unscientific, not investment advice.
About Stevanato Group
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.
- Founded
- 1980
- CEO
- Mr. Franco Stevanato
- Employees
- 6,010
- Headquarters
- Piombino Dese, Padova, Italy
- Fiscal year end
- 12-31
- Website
- stevanatogroup.com
Company profile
- Exchange
- US
- Symbol
- STVN
- Market-cap rank
- #2012
- Listing date
- 2021-07-16
- Market cap
- 5.31B
- Float cap
- 953.38M
- Shares out
- 273.13M
- Float shares
- 49.04M
Sectors & themes
Quote time 2026-10-07 20:03:48 · For reference only, not investment advice and not tailored to your situation.